CRC is resistant to TRAIL-driven apoptosis when the TRAIL signaling mechanism is defective (e.g., when TRAIL receptor is downregulated and anti-apoptotic protein level is increased) [18]. The gene discussed is TNFSF10; the disease is colorectal carcinoma.